H Partners Urges Harley-Davidson (HOG) Shareholders to Withhold Votes Against Zeitz, Linebarger, and Levinson After $6B Value Destruction

Keros Therapeutics (KROS) Faces ADAR1’s Push for Restructuring, $500M Capital Return, and Board Refresh

ADAR1 Capital Targets Keros Therapeutics (KROS) Board, Urges Withhold Votes Over Pipeline Failures and Cash Burn

Wynnefield Partners entered into a cooperation agreement with Quest Resource Holding Corp (QRHC)

BML Capital Urges AN2 Therapeutics, Inc. (ANTX) to Liquidate After Drug Failure

Harley-Davidson (HOG): H Partners Wins Proxy Advisor, Dealer Support to Oust CEO Zeitz and Two Long-Tenured Directors

H Partners Urges Shareholders to Withhold Votes at Harley-Davidson (HOG) Annual Meeting, Targeting CEO Zeitz and Longtime Directors for Value Destruction

ADAR1 Capital Presses Keros (KROS) to Halt Value-Destructive Programs, Focus on Takeda Partnership, and Add Shareholder Representation

ADAR1 Capital Slams Keros Therapeutics (KROS) Strategy, Urges Board Overhaul and Cash Return Amid Pipeline Concerns

BML Capital Presses AN2 (ANTX) to Return Cash to Shareholders, Warns Against Risky Preclinical Pivot

BML Capital Urges AN2 Therapeutics (ANTX) to Pursue Sale or Liquidation After Phase 3 Failure, Threatens Withhold Vote at Annual Meeting

Findell Capital Presses for Change at Oportun (OPRT), Citing Governance Failures, Cost Bloat, and Value-Destructive Acquisitions

Findell Capital Targets Oportun Financial (OPRT) Governance, Seeks Board Seat to End CEO Control and Refocus Strategy

13D weekly report - Apr 28, 2025 to May 02, 2025

Al Hartman Challenges Silver Star (SLVS) Over Distressed Sales, Cites $7.4M Value Loss and Puts Directors on Notice